Showing results (81-90 of 177) with videos related to
Sort By:
Pageof 18
Blood|July 18, 2013
Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trialCorey Cutler, Haesook T Kim, Bhavjot Bindra, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcomePhilippe Armand, Haesook T Kim, Vincent T Ho, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 25, 2010
Donor-derived second hematologic malignancies after cord blood transplantationKaren K Ballen, Corey Cutler, Beow Y Yeap, et al.Transplantation and Cellular Therapy|November 20, 2023
Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor AllograftJessica S Little, Rémy Duléry, Roman M Shapiro, et al.Blood|June 20, 2012
A disease risk index for patients undergoing allogeneic stem cell transplantationPhilippe Armand, Christopher J Gibson, Corey Cutler, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2013
Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemiaYi-Bin Chen, Erin Coughlin, Kevin F Kennedy, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2015
A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II TrialJohn Koreth, Haesook T Kim, Paulina B Lange, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2014
Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host diseaseCaron A Jacobson, Lixian Sun, Haesook T Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioningPhilippe Armand, Supriya Gannamaneni, Haesook T Kim, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 25, 2013
Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignanciesAndrew M Brunner, Haesook T Kim, Erin Coughlin, et al.Pageof 18